Pure Pharma News (@pharma_pure) header
Pure Pharma News (@pharma_pure) profile picture

We are a digital information company focusing on developments in the pharmaceutical and healthcare industry.

United Kingdom
Joined December 2020
Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)Photo by Pure Pharma News (@pharma_pure)
You can subscribe to our #free weekly newsletter of the top #pharmaceutical and #healthcare stories of the week. #newsletter #BigPharma #BiotechNews purepharmanews.com/subscribe…
1
1
2021 US #FDA approvals filled with first-in-class drugs. Find out more here ➡️purepharmanews.com/us-fda-nm… #Pharmaceuticals #pharmaindustry #regulatory
1
1
Cash injection for #Biogen as it sells its Samsung Bioepis stake for USD2.3bn #biosimilars #SamsungBioepis purepharmanews.com/biogen-se…
Pure Pharma News retweeted
Bioelectronic medicine may sound like sci-fi, but the concept is simple, and closer than you think! Swipe to see how #bioelectronics is aiming to tackle a range of chronic diseases using a small device implanted through keyhole surgery 👉 w/ @GBioelectronics

1
5
1
14
Check out the #PDUFA target action dates lined up for February and the key products awaiting approval.... purepharmanews.com/february-… #Pharmaceutical #FDA
PROTAC targeted protein degraders: the past is prologue go.nature.com/3rwBUQb - a new review by @miklosbekes and David Langley @ArvinasInc and @CraigMCrews covering the status of clinical translation of targeted protein degradation and key areas for the future of the field
54
4
156
As #Vimpat heads towards patent expiry, UCB agrees to acquire #Zogenix, which will bolster UCB's #epilepsy portfolio. purepharmanews.com/ucb-agree…
J&J aims to strengthen its multiple myeloma franchise with #teclistamab US FDA submission. #bloodcancer #cancer #Pharmaceuticals purepharmanews.com/teclistam…
1
Interested in upcoming #FDA #PDUFA goal dates for October? Find out more here: purepharmanews.com/october-2… #Pharmaceuticals
Pure Pharma News retweeted
FDA approves the first interchangeable biosimilar insulin product in the U.S. for the treatment of diabetes. Approval of insulin products can provide patients with additional safe, high-quality & potentially cost-effective options for treating diabetes. go.usa.gov/xFBYc
8
46
12
91